3
production verticals
Contract development and manufacturing of active pharmaceutical ingredients, finished dosage forms and food products — with a meticulous approach to creating or designing around intellectual property.
We work with highly qualified partners across all areas — from synthesis to regulatory filings.
PHZAPPA combines chemistry, process technology and legal strategy. We take a product from idea and substance synthesis through to a validated form and a registration dossier — while building the patent perimeter that strengthens the client’s market position.
We build a full production cycle for the final product that does not depend on regulatory policy: every production stage is held as the client’s intellectual property.
Synthetic route design, substance production, impurity control and DMF preparation.
Practically every available dosage form, tailored to your site.
Functional ingredients and nutraceuticals: recipes, safety, stability, originality.
We deliberately create intellectual property — patents related to the substance, composition or technology — so the client gains a defensible market position.
“Without deviation from the norm, progress is not possible.”
A transparent route — from first brief to rights transfer and scale-up.
Goals, patent search and patent-clearance assessment.
Substance synthesis and formulation, analytics and stability.
Filings on synthesis technologies, composition and other position-strengthening features and technologies in RF and EAPO.
Production, validation and transfer of rights to the client.
The company is ready to attract investment both into expanding its own CDMO capacity and into drug development — generic and original.
Investment into in-house manufacturing and laboratory capacity across all verticals.
The investor becomes the principal beneficiary, while we take on every stage of development and registration.
We have already assembled several investment portfolios that we are ready to offer to investors.
Active projects and candidates are under NDA. Pipeline contents and readiness stages are shared with partners and investors after a confidentiality agreement is signed.
Request accessTell us about the task — we’ll respond on development, manufacturing and patent options.